Table 5

Treatment-related adverse events

Adverse eventNo (%) of patients
Bimatoprost (nā€Š=ā€Š131)Travoprost (nā€Š=ā€Š133)
Eye pruritus3 (2.3%)1 (0.8%)
Conjunctival or ocular hyperaemia4 (3.1%)2 (1.5%)
Punctate keratitis1 (0.8%)2 (1.5%)
Eye irritation2 (1.5%)0 (0.0%)
Growth of eyelashes2 (1.5%)0 (0.0%)
Abnormal sensation in eye1 (0.8%)0 (0.0%)
Drug hypersensitivity0 (0.0%)1 (0.8%)
Dry skin1 (0.8%)0 (0.0%)
Foreign-body sensation0 (0.0%)1 (0.8%)
Hyperaemia (non-ocular)0 (0.0%)1 (0.8%)
Pruritus at instillation site0 (0.0%)1 (0.8%)
Skin pigmentation1 (0.8%)0 (0.0%)
Visual acuity reduced0 (0.0%)1 (0.8%)
Overall*11 (8.4%)8 (6.0%)
  • *Patients reporting any treatment-related adverse event.